Success Metrics

Clinical Success Rate

83.0%

Based on 39 completed trials

Completion Rate

83%(39/47)

Active Trials

32(30%)

Results Posted

46%(18 trials)

Terminated

8(8%)

Phase Distribution

Ph phase_1

Ph early_phase_1

Ph phase_2

Ph not_applicable

73%

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution91 total trials

Early Phase 1First-in-human

3(3.3%)

Phase 1Safety & dosage

4(4.4%)

Phase 2Efficacy & side effects

5(5.5%)

Phase 4Post-market surveillance

2(2.2%)

N/ANon-phased studies

77(84.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.5%

39 of 51 finished

Non-Completion Rate

23.5%

12 ended early

Currently Active

trials recruiting

Total Trials

105

all time

Status Distribution

Active(38)

Completed(39)

Terminated(12)

Other(16)

Detailed Status

Completed39

Recruiting26

unknown15

Terminated8

Active, not recruiting6

Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials

105

Active

Success Rate

83.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 13 (3.3%)

Phase 14 (4.4%)

Phase 25 (5.5%)

Phase 42 (2.2%)

N/A77 (84.6%)

Trials by Status

terminated88%

unknown1514%

completed3937%

enrolling_by_invitation22%

not_yet_recruiting44%

active_not_recruiting66%

suspended11%

withdrawn44%

recruiting2625%

Recent Activity

32 active trials

Showing 5 of 105

not_yet_recruitingnot_applicable

The PREVENT Resilience Study

NCT07568145

recruitingnot_applicable

Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans

NCT05368987

recruitingphase_2

Clinical Trials (105)

Showing 20 of 105 trialsScroll for more

NCT07568145Not Applicable

The PREVENT Resilience Study

Not Yet Recruiting

NCT05368987Not Applicable

Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans

Recruiting

NCT06968663Phase 2

Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia

Recruiting

NCT03386188Not Applicable

Role of the Posterior Parietal Cortex in the Processing of Sensory Information

Terminated

NCT07530536Not Applicable

rTMS for Postoperative Brain Tumor Patients

Recruiting

NCT05861284Not Applicable

Developing and Optimizing Transcranial Magnetic Stimulation for Motor Rehabilitation

Withdrawn

NCT07525063Not Applicable

Pain & Reward Neuromodulation of CNS Circuits

Not Yet Recruiting

NCT06748274Not Applicable

The Brain-Heart-Gut Connection

Completed

NCT06328114Not Applicable

Accelerating TMS for Cervical Dystonia

Enrolling By Invitation

NCT07457567Not Applicable

Neural Mechanisms of the Social Brain

Not Yet Recruiting

NCT06015672Not Applicable

Accelerated TMS for Focal Hand Dystonia

Active Not Recruiting

NCT06842745Phase 2

Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia

Recruiting

NCT03622749Not Applicable

Pilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders

Completed

NCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

Recruiting

NCT06266390Not Applicable

Individualized (fMRI-guided) TMS Treatment for Depression

Active Not Recruiting

NCT07397897Not Applicable

Intracranial EEG to Test How Noninvasive Stimulation Affects Hippocampal-dependent Memory

Enrolling By Invitation

NCT04936009Not Applicable

Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)

Recruiting

NCT06648642Not Applicable

Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)

Recruiting

NCT04242355Not Applicable

Transcranial Magnetic Stimulation on Neural and Behavioral Facets of Social Cognition in Autism Spectrum Disorder

Active Not Recruiting

NCT07223619Not Applicable

PILOT Phase: BPD Study

Active Not Recruiting

Drug Details

Intervention Type: DEVICE
Total Trials: 105